GENERAL PHARMACEUTICAL COUNCIL
Revalidation Evaluation Partner
This sits in the lower-middle of the Research & Development band — a mid-scale opportunity. Based on 20,405 valued Research & Development tenders in our corpus.
The aim of this project is to undertake a review of our revalidation process, engaging with internal and stakeholders and analysing revalidation data.
The evaluation should consider the revalidation process from the perspective of the registrant (both pharmacists and pharmacy technicians), other stakeholders and from the GPhC perspective.
The focus should be on the current set- up and consideration for future changes, but not on previous iterations.
What the supplier must deliver
The evaluation should consider the revalidation process
The evaluation should consider the revalidation process from the perspective of the registrant (both pharmacists and pharmacy technicians), other stakeholders and from the GPhC perspective.
The focus should be on the current
The focus should be on the current set- up and consideration for future changes, but not on previous iterations.
Derived from the notice text — always confirm against the original documents.
Make the case to bid
Reveal who to approach at GENERAL PHARMACEUTICAL COUNCIL, and generate a go-to-market strategy from their news, accounts and people.
- OCID
- 3745e3b4-c862-4d06-81bf-cd3e436ba41c
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- GPhC098
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Research & Development
Assembling the market network…
GENERAL PHARMACEUTICAL COUNCIL’s tender network
Assembling the network…